Stocktoria
Sartorius Aktiengesellschaft SRT.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Sartorius Aktiengesellschaft financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €3.5B | €3.4B | €3.4B | €4.2B |
| Gross profit | €1.6B | €1.5B | €1.6B | €2.2B |
| R&D expense | €174.0M | €196.8M | €170.8M | €179.2M |
| SG&A expense | €896.6M | €884.0M | €848.5M | €846.1M |
| Operating income | €569.2M | €437.2M | €543.9M | €1.1B |
| Interest expense | €174.3M | €184.1M | €144.9M | €35.2M |
| Income tax | €106.5M | €49.4M | €96.1M | €268.6M |
| Net income | €154.9M | €84.0M | €205.6M | €678.1M |
| EPS (diluted) | €2.24 | €1.21 | €3.00 | €9.91 |
| Operating cash flow | €837.0M | €976.2M | €853.6M | €734.2M |
| Free cash flow | €395.1M | €566.3M | €293.9M | €211.6M |
| Cash & equivalents | €541.4M | €813.4M | €379.2M | €165.9M |
| Inventory | €792.2M | €788.5M | €1.0B | €1.2B |
| Goodwill | €3.5B | €3.5B | €3.5B | €1.7B |
| Total assets | €9.7B | €10.1B | €9.7B | €7.0B |
| Total debt | €4.3B | €4.6B | €5.3B | €2.5B |
| Total liabilities | €5.8B | €6.2B | €7.0B | €4.3B |
| Shareholders' equity | €2.7B | €2.8B | €2.1B | €2.0B |
Growth · year-over-year · Revenue CAGR -5.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +4.7% | -0.4% | -18.7% | — |
| Net income growth | +84.4% | -59.1% | -69.7% | — |
| EPS growth | +85.1% | -59.7% | -69.7% | — |
| Free cash flow growth | -30.2% | +92.7% | +38.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · DE · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.